i2 Pharma Solutions has extensive experience developing and validating HPLC methods for assay and impurity testing of drug substances and drug products. Using a phase-appropriate approach, our team supports drug development efficiently in terms of time and cost without compromising quality or compliance.

Aqueous solubility across biorelevant pH conditions is a key biopharmaceutical property of an API that influences the bioavailability of oral dosage forms. However, many APIs have poor aqueous solubility. i2 Pharma Solutions specializes in addressing this challenge through advanced technologies such as spray drying and hot melt extrusion, converting poorly soluble APIs into higher-performing amorphous dispersions.

Solid oral dosage forms are the most widely used delivery format, and most drugs are developed and commercialized in this form. i2 Pharma Solutions specializes in developing high-quality solid oral formulations that are robust, scalable, and aligned with regulatory expectations. Drawing on our expertise in preformulation, excipient selection, and process optimization, we design formulations that deliver consistent performance, manufacturability, and bioavailability.